Cargando…
Long-term somatic side-effects and morbidity in testicular cancer patients.
In order to evaluate long-term somatic morbidity after treatment for testicular cancer 149 patients with NED greater than or equal to 3 years answered a questionnaire. The patients had been treated with surgery only (32 patients, radiotherapy only (39 patients), cisplatin-based chemotherapy plus sur...
Autores principales: | , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1990
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971317/ https://www.ncbi.nlm.nih.gov/pubmed/2297486 |
_version_ | 1782134884107550720 |
---|---|
author | Aass, N. Kaasa, S. Lund, E. Kaalhus, O. Heier, M. S. Fosså, S. D. |
author_facet | Aass, N. Kaasa, S. Lund, E. Kaalhus, O. Heier, M. S. Fosså, S. D. |
author_sort | Aass, N. |
collection | PubMed |
description | In order to evaluate long-term somatic morbidity after treatment for testicular cancer 149 patients with NED greater than or equal to 3 years answered a questionnaire. The patients had been treated with surgery only (32 patients, radiotherapy only (39 patients), cisplatin-based chemotherapy plus surgery (46 patients) or chemotherapy plus radiotherapy with or without surgery (32 patients). Raynaud-like phenomena were the most frequent side-effect occurring significantly more often after cisplatin-based chemotherapy than after surgery or radiotherapy (33/72 patients versus 5/68 patients). Peripheral sensory 'neuropathy' was reported by 18% of all the patients. Seventeen per cent and 11% complained of pulmonary symptoms and auditory symptoms, respectively. Gastrointestinal side-effects were more frequent after any type of cytotoxic therapy than after surgery only (34/47 patients versus 5/22 patients). Twenty-six patients had fathered children after treatment. About 80% of the patients were in full time wage-earning activity when they answered the questionnaire. In conclusion, 3-7 years after treatment for testicular cancer, 30-50% of the patients had minor somatic complaints whereas serious side-effects seldom occurred. |
format | Text |
id | pubmed-1971317 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1990 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-19713172009-09-10 Long-term somatic side-effects and morbidity in testicular cancer patients. Aass, N. Kaasa, S. Lund, E. Kaalhus, O. Heier, M. S. Fosså, S. D. Br J Cancer Research Article In order to evaluate long-term somatic morbidity after treatment for testicular cancer 149 patients with NED greater than or equal to 3 years answered a questionnaire. The patients had been treated with surgery only (32 patients, radiotherapy only (39 patients), cisplatin-based chemotherapy plus surgery (46 patients) or chemotherapy plus radiotherapy with or without surgery (32 patients). Raynaud-like phenomena were the most frequent side-effect occurring significantly more often after cisplatin-based chemotherapy than after surgery or radiotherapy (33/72 patients versus 5/68 patients). Peripheral sensory 'neuropathy' was reported by 18% of all the patients. Seventeen per cent and 11% complained of pulmonary symptoms and auditory symptoms, respectively. Gastrointestinal side-effects were more frequent after any type of cytotoxic therapy than after surgery only (34/47 patients versus 5/22 patients). Twenty-six patients had fathered children after treatment. About 80% of the patients were in full time wage-earning activity when they answered the questionnaire. In conclusion, 3-7 years after treatment for testicular cancer, 30-50% of the patients had minor somatic complaints whereas serious side-effects seldom occurred. Nature Publishing Group 1990-01 /pmc/articles/PMC1971317/ /pubmed/2297486 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Research Article Aass, N. Kaasa, S. Lund, E. Kaalhus, O. Heier, M. S. Fosså, S. D. Long-term somatic side-effects and morbidity in testicular cancer patients. |
title | Long-term somatic side-effects and morbidity in testicular cancer patients. |
title_full | Long-term somatic side-effects and morbidity in testicular cancer patients. |
title_fullStr | Long-term somatic side-effects and morbidity in testicular cancer patients. |
title_full_unstemmed | Long-term somatic side-effects and morbidity in testicular cancer patients. |
title_short | Long-term somatic side-effects and morbidity in testicular cancer patients. |
title_sort | long-term somatic side-effects and morbidity in testicular cancer patients. |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971317/ https://www.ncbi.nlm.nih.gov/pubmed/2297486 |
work_keys_str_mv | AT aassn longtermsomaticsideeffectsandmorbidityintesticularcancerpatients AT kaasas longtermsomaticsideeffectsandmorbidityintesticularcancerpatients AT lunde longtermsomaticsideeffectsandmorbidityintesticularcancerpatients AT kaalhuso longtermsomaticsideeffectsandmorbidityintesticularcancerpatients AT heierms longtermsomaticsideeffectsandmorbidityintesticularcancerpatients AT fossasd longtermsomaticsideeffectsandmorbidityintesticularcancerpatients |